Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics. (2014)
Attributed to:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13073-014-0116-0
PubMed Identifier: 25587359
Publication URI: http://europepmc.org/abstract/MED/25587359
Type: Journal Article/Review
Volume: 6
Parent Publication: Genome medicine
Issue: 12
ISSN: 1756-994X